Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT00906516
Title Neuradiab Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bradmer Pharmaceuticals Inc.
Age Groups: adult
Covered Countries USA

No variant requirements are available.